ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
4 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
2.7K
|
1.0M
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
2.7K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Chart
|
|
bioqld
|
32 |
17K |
4 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
32
|
17K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
2.7K
|
1.0M
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
bioqld
|
51 |
23K |
3 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
51
|
23K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
bioqld
|
51 |
23K |
21 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
51
|
23K
|
21
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
bioqld
|
51 |
23K |
9 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
51
|
23K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
bioqld
|
51 |
23K |
4 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
51
|
23K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
bioqld
|
51 |
23K |
5 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
51
|
23K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
1 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
2.7K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
6 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
2.7K
|
1.0M
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
bioqld
|
51 |
23K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
51
|
23K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
bioqld
|
51 |
23K |
11 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
51
|
23K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
bioqld
|
51 |
23K |
15 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
51
|
23K
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Marc do your job!
|
|
bioqld
|
42 |
18K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
42
|
18K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Ceasing to be a substantial holder
|
|
bioqld
|
11 |
5.0K |
9 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
11
|
5.0K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
bioqld
|
743 |
331K |
13 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
743
|
331K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Marc do your job!
|
|
bioqld
|
42 |
18K |
18 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
42
|
18K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
Ann: CHDR to conduct first-in-human phase 1 trial of IMP761
|
|
bioqld
|
10 |
4.2K |
6 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
10
|
4.2K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: CHDR to conduct first-in-human phase 1 trial of IMP761
|
|
bioqld
|
10 |
4.2K |
15 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
10
|
4.2K
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Ceasing to be a substantial holder
|
|
bioqld
|
11 |
5.0K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
11
|
5.0K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
17 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
2.7K
|
1.0M
|
17
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
2.7K
|
1.0M
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
bioqld
|
743 |
331K |
1 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
743
|
331K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
bioqld
|
743 |
331K |
22 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
743
|
331K
|
22
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
bioqld
|
56 |
30K |
21 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
56
|
30K
|
21
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
3 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
2.7K
|
1.0M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
bioqld
|
56 |
30K |
7 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
56
|
30K
|
7
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Letter to Shareholders - GM
|
|
bioqld
|
4 |
1.7K |
10 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
4
|
1.7K
|
10
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Regeneus enters into binding merger agreement with Cambium
|
|
bioqld
|
4 |
1.6K |
1 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
4
|
1.6K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
bioqld
|
2 |
889 |
7 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
2
|
889
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: PEI provides constructive feedback for ph3 lung cancer trial
|
|
bioqld
|
8 |
6.1K |
4 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
8
|
6.1K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
15 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
2.7K
|
1.0M
|
15
|
|
ASX - By Stock
|
IMM |
Re:
The reason for the price increase ???
|
|
bioqld
|
19 |
10K |
11 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
19
|
10K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
The reason for the price increase ???
|
|
bioqld
|
19 |
10K |
8 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
19
|
10K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
2 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
2.7K
|
1.0M
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
7 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
2.7K
|
1.0M
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
16 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
2.7K
|
1.0M
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Only a matter of time
|
|
bioqld
|
19 |
10K |
5 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
19
|
10K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Only a matter of time
|
|
bioqld
|
19 |
10K |
18 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
19
|
10K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
bioqld
|
743 |
331K |
7 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
743
|
331K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
19 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
2.7K
|
1.0M
|
19
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
16 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
2.7K
|
1.0M
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
15 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
2.7K
|
1.0M
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
11 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
2.7K
|
1.0M
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
bioqld
|
2.7K |
1.0M |
3 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
2.7K
|
1.0M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Webcast slides for new Efti clinical data in 1st line NSCLC
|
|
bioqld
|
25 |
10K |
10 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
25
|
10K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Webcast slides for new Efti clinical data in 1st line NSCLC
|
|
bioqld
|
25 |
10K |
16 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
25
|
10K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Webcast slides for new Efti clinical data in 1st line NSCLC
|
|
bioqld
|
25 |
10K |
11 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
25
|
10K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Webcast slides for new Efti clinical data in 1st line NSCLC
|
|
bioqld
|
25 |
10K |
3 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
25
|
10K
|
3
|
|